Use of telemedicine and helicopter transport to improve stroke care in remote locations
{{output}}
Intravenous recombinant tissue plasminogen activator is the only medication approved by the US Food and Drug Administration for treatment of acute stoke. Despite established efficacy, less than 3% of stroke patients receive treatment, and that number is even s... ...
